Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes.
Saved in:
| Title: | Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes. |
|---|---|
| Authors: | Zeidan AM; Section of Hematology, Department of Medicine, Yale School of Medicine, and Yale Cancer Center, Smilow Cancer Hospital, New Haven, CT. Electronic address: amer.zeidan@yale.edu., Joshi N; OPEN Health, Bethesda, MD., Kale H; OPEN Health, Bethesda, MD., Wang WJ; OPEN Health, Bethesda, MD., Corman S; OPEN Health, Bethesda, MD., Salimi T; Taiho Oncology Inc., Princeton, NJ., Epstein RS; Epstein Health LLC, Woodcliff Lake, NJ. |
| Source: | Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Sep; Vol. 22 (9), pp. 670-679. Date of Electronic Publication: 2022 Apr 22. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35614009 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zeidan+AM%22">Zeidan AM</searchLink>; Section of Hematology, Department of Medicine, Yale School of Medicine, and Yale Cancer Center, Smilow Cancer Hospital, New Haven, CT. Electronic address: amer.zeidan@yale.edu.<br /><searchLink fieldCode="AU" term="%22Joshi+N%22">Joshi N</searchLink>; OPEN Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Kale+H%22">Kale H</searchLink>; OPEN Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Wang+WJ%22">Wang WJ</searchLink>; OPEN Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Corman+S%22">Corman S</searchLink>; OPEN Health, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Salimi+T%22">Salimi T</searchLink>; Taiho Oncology Inc., Princeton, NJ.<br /><searchLink fieldCode="AU" term="%22Epstein+RS%22">Epstein RS</searchLink>; Epstein Health LLC, Woodcliff Lake, NJ. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101525386%22">Clinical lymphoma, myeloma & leukemia</searchLink> [Clin Lymphoma Myeloma Leuk] 2022 Sep; Vol. 22 (9), pp. 670-679. <i>Date of Electronic Publication: </i>2022 Apr 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101525386 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2152-2669 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221522669%22">21522669 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lymphoma Myeloma Leuk <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35614009 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.clml.2022.04.016 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 670 Titles: – TitleFull: Impact of Hypomethylating Agent Use on Hospital and Emergency Room Visits, and Predictors of Early Discontinuation in Patients With Higher-Risk Myelodysplastic Syndromes. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zeidan AM – PersonEntity: Name: NameFull: Joshi N – PersonEntity: Name: NameFull: Kale H – PersonEntity: Name: NameFull: Wang WJ – PersonEntity: Name: NameFull: Corman S – PersonEntity: Name: NameFull: Salimi T – PersonEntity: Name: NameFull: Epstein RS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2022 Sep Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2152-2669 Numbering: – Type: volume Value: 22 – Type: issue Value: 9 Titles: – TitleFull: Clinical lymphoma, myeloma & leukemia Type: main |
| ResultId | 1 |
